GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Dividend-Payout-to-FFO

JW Pharmaceutical (XKRX:001060) Dividend-Payout-to-FFO


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


JW Pharmaceutical (XKRX:001060) Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.